Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04246177
Brief Title: Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

First Submitted : January 27, 2020
First Submitted that Met QC Criteria : January 27, 2020
First Posted : January 29, 2020

Last Update Submitted that Met QC Criteria : October 13, 2021
Last Update Posted : October 14, 2021